Recent Articles from GlobeNewswire
SHANGHAI, April 01, 2025 (GLOBE NEWSWIRE) -- EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T-cell engagers, is pleased to announce the company will be presenting four poster presentations at the upcoming 2025 American Association for Cancer Research (AACR) Annual Meeting taking place in Chicago, Illinois, from April 25-30, 2025, at the McCormick Place Convention Center.
By Shanghai EpimAb Biotherapeutics Co., Ltd. · Via GlobeNewswire · March 31, 2025
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates, “Base Carbon”, or the “Company”), announced today a change to the timing of previously announced 2024 year-end investor update call. The call will now be held on Tuesday, April 1, at 3:00 p.m. Eastern Time (EDT).
By Base Carbon Inc. · Via GlobeNewswire · March 31, 2025
Plan provides a roadmap for customers’ future energy needs
By Avista Corporation · Via GlobeNewswire · March 31, 2025
New Integration Eliminates Data Silos, Drives Manufacturing Efficiency
By LLumin · Via GlobeNewswire · March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Siddhi Acquisition Corp. (“Siddhi Acquisition” or the “Company”) announced today that it priced its upsized initial public offering of 24,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “SDHIU” beginning April 1, 2025. Each unit consists of one Class A ordinary share and one right entitling the holder thereof to receive one tenth of one Class A ordinary share upon the consummation of an initial business combination. The Class A ordinary shares and rights comprising the units are expected to begin separate trading no later than the 52nd day following this date. Once the securities comprising the units begin separate trading, the Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols “SDHI” and “SDHIR”, respectively.
By Siddhi Acquisition Corp · Via GlobeNewswire · March 31, 2025
Overall change in electric prices would be effective July 1, 2025
By Avista Corporation · Via GlobeNewswire · March 31, 2025
Six Senior Managing Directors and a Managing Director Build on February’s Practice Launch
By FTI Consulting, Inc. · Via GlobeNewswire · March 31, 2025
ENGLEWOOD, Colo, March 31, 2025 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO) (“Gevo”, the “Company”, “we”, “us” or “our”), a leading developer of cost effective, renewable hydrocarbon fuels and chemicals with reduced greenhouse gas emissions, announced today that Eric Frey, Gevo’s Vice President of Corporate Development, will participate in a Renmark Virtual Non-Deal Roadshow Series on Tuesday, April 1st at 10:00am ET.
By Gevo, Inc. · Via GlobeNewswire · March 31, 2025
SAN JOSE, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- SJW Group (NASDAQ: SJW), a leading national investor-owned pure-play water and wastewater utility, today announced that its Board of Directors has appointed Ann P. Kelly as Chief Financial Officer (CFO) and Treasurer, effective July 1, 2025. Kelly, who joined SJW Group in November 2024 as Chief Accounting Officer, has already played a key role in advancing the company’s business transformation and operational excellence.
By SJW Group · Via GlobeNewswire · March 31, 2025
SAN DIEGO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) is pleased to announce that Andrew Cardno, Chief Technology & Growth Officer (CTO) at QCI, will be presenting at the Indian Gaming Association Trade Show on April 3rd at noon in San Diego, California. His session, titled “Predicting the Future: How AI & Analytics Will Revolutionize Tribal Gaming,” will delve into how artificial intelligence and data analytics are rapidly transforming the gaming industry, particularly within tribal gaming operations.
By QCI · Via GlobeNewswire · March 31, 2025
Poplar Bluff, Missouri, March 31, 2025 (GLOBE NEWSWIRE) --
By Southern Missouri Bancorp, Inc. · Via GlobeNewswire · March 31, 2025
OKLAHOMA CITY, March 31, 2025 (GLOBE NEWSWIRE) -- Federman & Sherwood investigates Southeast Series of Lockton Companies, LLC (“Lockton”) for data breach. On February 28, 2025, Lockton filed notice of a data breach with the Attorney General of Massachusetts. Lockton experienced a cybersecurity incident involving their network on November 20, 2024. Lockton immediately launched an investigation into the incident. The investigation determined that an unauthorized third party gained access to Lockton’s network and accessed certain individuals’ personal and sensitive information. On February 28, 2025, Lockton began to send out data breach notification letters to all individuals impacted by the data breach.
By Federman & Sherwood · Via GlobeNewswire · March 31, 2025
SEATTLE, March 31, 2025 (GLOBE NEWSWIRE) -- As demand grows for more interactive and diverse NSFW AI sites, users are looking to Crushon AI with increasing frequency as a solid Janitor AI substitute. Crushon AI's specialty in AI companionship and virtual interaction for adults is setting new benchmarks within consumers of the burgeoning conversational AI industry.
By CRUSHON AI CORP · Via GlobeNewswire · March 31, 2025
LOS ANGELES, March 31, 2025 (GLOBE NEWSWIRE) -- MediaAlpha, Inc. (NYSE: MAX) (“MediaAlpha” or the “Company”) today announced the appointment of Bradley Hunt to its Board of Directors.
By MediaAlpha, Inc. · Via GlobeNewswire · March 31, 2025
Medford, OR, March 31, 2025 (GLOBE NEWSWIRE) -- In an industry driven by trends, The Human Bean continues to set them. As a pioneer in specialty beverages, the brand is redefining customer engagement through data-driven seasonal innovations and category expansion.
By The Human Bean · Via GlobeNewswire · March 31, 2025
BALTIMORE, March 31, 2025 (GLOBE NEWSWIRE) -- MarketWise, Inc. (NASDAQ: MKTW) (“MarketWise” or “the Company”), a leading multi-brand digital subscription services platform that provides premium financial research, software, education, and tools for self-directed investors, announced that it will effect a 1-for-20 reverse stock split of its common stock, par value $0.0001 per share, effective at 5:00 p.m. Eastern Time on April 2, 2025. The Company’s Class A common stock will begin trading on a reverse-split-adjusted basis when the markets open on April 3, 2025. The Company’s Class A common stock will continue to trade on the Nasdaq Global Market under the symbol "MKTW." The new CUSIP number for the Company’s Class A common stock following the reverse stock split will be 57064P206.
By MarketWise LLC · Via GlobeNewswire · March 31, 2025
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- BIGG Digital Assets Inc. (“BIGG” or the “Company”)(TSXV: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of TerraZero, Netcoins and Blockchain Intelligence Group, is pleased to announce that TerraZero Technologies has opened the public beta of its Intraverse platform as of Monday, March 31, 2025.
By BIGG Digital Assets Inc. · Via GlobeNewswire · March 31, 2025
PLANO, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the leading franchisor and operator of out-of-home waxing services in the United States, announced that effective as of March 31, 2025, the Company’s Board of Directors approved grants of (i) restricted stock units covering 84,000 shares of the Company’s Class A common stock (the “RSUs”), (ii) non-qualified stock option awards to purchase 130,000 shares of the Company’s Class A common stock with an exercise price of $3.95, which is equal to the closing price of the Company’s Class A common stock on the Nasdaq Stock Market on March 31, 2025, (iii) non-qualified stock option awards to purchase 95,000 shares of the Company’s Class A common stock with an exercise price of $9.00, and (iv) non-qualified stock option awards to purchase 95,000 shares of the Company’s Class A common stock with an exercise price of $12.00 ((ii), (iii) and (iv) collectively, the “Options”) to one new employee.
By European Wax Center, Inc. · Via GlobeNewswire · March 31, 2025
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U) announces additional details regarding its upcoming hybrid annual shareholders’ meeting. As disclosed in our annual meeting materials and on our website, the hybrid meeting will be held both in-person and virtually on April 10, 2025 and will commence at 9:30 a.m. Eastern Time, with the formal annual meeting and a presentation by Prem Watsa, Fairfax’s Chairman and CEO, followed by a Q&A session, all of which will be webcast in real time. Following are additional details on how to access this webcast and to submit questions in advance for the Q&A session.
By Fairfax Financial Holdings Limited · Via GlobeNewswire · March 31, 2025
Singapore, March 31, 2025 (GLOBE NEWSWIRE) -- Springview Holdings Ltd (Nasdaq: SPHL) (“Springview Holdings”, or the “Company”), a company which designs and constructs residential and commercial buildings in Singapore with an operating history dating back to 2002, today announced what it believes to be a significant further expansion of its revenue opportunities after its indirect wholly owned Singapore operating subsidiary, Springview Enterprises Pte. Ltd. (“Springview Singapore”), received two new important government certifications from the Building and Construction Authority in Singapore (“BCA”), namely the CW01 and CW02 certifications. These certifications will enable Springview Singapore to bid for small-scale public sector projects and the Company therefore expects that these certifications will allow Springview Singapore to significantly expand its addressable market.
By SPRINGVIEW HOLDINGS LTD · Via GlobeNewswire · March 31, 2025
STAFFORD, Texas, March 31, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ:MVST) (“Microvast” or the “Company”), a global leader in advanced battery technologies, announced today its consolidated financial results for the fourth quarter and full fiscal year ended December 31, 2024 (“Q4 2024” and “FY 2024,” respectively).
By Microvast, Inc. · Via GlobeNewswire · March 31, 2025
Company announcement – No. 8 / 2025
By Zealand Pharma · Via GlobeNewswire · March 31, 2025
FY 2024 Annual Revenue Growth to $5.9 Million and Strong 31% Increase in Q4 Revenue to $1.8 Million
By Reborn Coffee, Inc. · Via GlobeNewswire · March 31, 2025
By STMicroelectronics International NV · Via GlobeNewswire · March 31, 2025
LUXEMBOURG, March 31, 2025 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced that the distribution of its previously disclosed issuance of Stakeholder Warrants will take place on April 3, 2025 (the “Distribution Date”). Altisource previously announced the proposed issuance under Luxembourg law under the authorized share capital mechanism, which is more commonly referred to as a distribution in the United States (the “Warrant Distribution”), of transferable Warrants (as defined below) to holders (collectively, the “Stakeholders”) of Altisource’s (i) common stock (the “Common Stock”), (ii) restricted share units (“RSUs”) and (iii) outstanding warrants to purchase shares of Common Stock at an exercise price of $0.01 per share (“Penny Warrants”), in each case, as of 5:00 p.m., New York City time, on February 14, 2025 (the “Distribution Record Date”). The Warrant Distribution was contingent upon, among other things, approval by the Company’s shareholders of the proposals set forth in the Company’s definitive proxy statement on Schedule 14A filed with the SEC on January 3, 2025 and the consummation of the transactions contemplated by the previously disclosed Transaction Support Agreement (such conditions, collectively, the “Distribution Conditions”). As the Distribution Conditions have been satisfied, Altisource is proceeding with the Warrant Distribution.
By Altisource Portfolio Solutions S.A. · Via GlobeNewswire · March 31, 2025
BALA CYNWYD, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · March 31, 2025
COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS® (Smallpox and Mpox Vaccine, Live, Non-replicating) for prevention of smallpox and mpox disease in adults 18 years of age and older. This approval will provide additional flexibility for stockpiling against a smallpox event or mpox outbreak.
By Bavarian Nordic A/S · Via GlobeNewswire · March 31, 2025
Quarterly Adjusted EBITDA of $1.9 Million in Q4, a $4.9 Million Improvement YoY
By Enthusiast Gaming Inc. · Via GlobeNewswire · March 31, 2025
As fire departments prepare to migrate to new national data standards, ESO’s integration to NERIS reduces burden, ensures compliance
By ESO Solutions, Inc. · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Presidio Property Trust, Inc. (Nasdaq: SQFT, SQFTP, SQFTW) (the “Company”), an internally managed, diversified real estate investment trust (“REIT”), today reported earnings for its year ended December 31, 2024.
By Presidio Property Trust, Inc. · Via GlobeNewswire · March 31, 2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in April:
By ORIC Pharmaceuticals · Via GlobeNewswire · March 31, 2025
SAXONBURG, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, will show a live demonstration of its silicon photonics-based 1.6T-DR8 transceiver module using a Marvell® Ara 3nm optical digital signal processor (DSP) at OFC 2025. This transceiver features 200 Gbps electrical and optical interfaces.
By Coherent Corp. · Via GlobeNewswire · March 31, 2025
HONG KONG, March 31, 2025 (GLOBE NEWSWIRE) -- Intercont (Cayman) Limited (“Intercont” or the “Company”), a global shipping enterprise with plans for seaborne pulping operations, today announced the closing of its public offering (the “Offering”) of 1,500,000 ordinary shares (the “Ordinary Shares”) at a public offering price of $7.00 per share (the “IPO”). The Company received the gross proceeds of $10,500,000 from the Offering, before deducting underwriting discounts and offering expenses. The Ordinary Shares commenced trading on the Nasdaq Capital Market on March 28, 2025 under the ticker symbol "NCT."
By Intercont Cayman · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced registered direct offering, with a single institutional investor, for the issuance and sale of 3,325,000 shares of the Company’s common stock, and pre-funded warrants to purchase up to 2,728,000 shares of Common Stock. In a concurrent private placement, the Company issued and sold to the investor Series G common warrants to purchase up to an aggregate of 6,053,000 shares common stock.
By Calidi Biotherapeutics, Inc · Via GlobeNewswire · March 31, 2025
Broad-Based Sales Growth: New Customers Up 30%, Subscriptions Up 48%, Remote Guarding Up 404%, Hardware Sales Up 250%
By CLOUDASTRUCTURE, INC. · Via GlobeNewswire · March 31, 2025
Netanya, Israel, March 31, 2025 (GLOBE NEWSWIRE) -- Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and developer of ruggedized tactical communication headset devices as well as other communication accessories, today announced that it intends to offer to sell ordinary shares in an underwritten public offering. All of the ordinary shares are to be sold by the Company. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.
By Silynxcom Ltd. · Via GlobeNewswire · March 31, 2025
Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing all required safety testing
By Fibrobiologics, Inc. · Via GlobeNewswire · March 31, 2025
NEW HOPE, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2024 financial results and provided a fourth quarter business update.
By Orchestra BioMed Holdings, Inc. · Via GlobeNewswire · March 31, 2025
BOSTON, March 31, 2025 (GLOBE NEWSWIRE) -- - Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the treatment of cancer and autoimmune disease, today reported fourth quarter and full year 2024 financial results.
By Cue Biopharma, Inc. · Via GlobeNewswire · March 31, 2025
SHANGHAI, March 31, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech provider, today announced the completion of the underwritten public offering (the “Offering”) of 25,000,000 Class A ordinary shares of the Company (the “Ordinary Shares”), at a public offering price of US$1.80 per share. The Company has granted the underwriters in the Offering a 30-day option to purchase up to an additional 3,750,000 Ordinary Shares.
By ECARX LIMITED · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its first quarter 2025 earnings in a press release to be issued after the market closes on Tuesday, April 29, 2025.
By American Assets Trust, Inc. · Via GlobeNewswire · March 31, 2025
HONESDALE, Pa., March 31, 2025 (GLOBE NEWSWIRE) -- James O. Donnelly, President and Chief Executive Officer of Norwood Financial Corp (NASDAQ Global Market - NWFL) and its subsidiary Wayne Bank, announced that the Board of Directors has declared a $0.31 per share cash dividend, which is payable on May 1, 2025, to stockholders of record as of April 15, 2025. The $0.31 per share is a $0.01 increase over the per share dividend declared in the first quarter of 2024.
By Norwood Financial Corp · Via GlobeNewswire · March 31, 2025
- Grew Total Revenue 8% Year-over-Year to $45 Million in the Fourth Quarter 2024 -
By Binah Capital Group · Via GlobeNewswire · March 31, 2025
A Series of Milestones, Including Public Listing, Were Achieved in 2024; Longanesi First Gas Production Has Been Achieved
By AleAnna, Inc. · Via GlobeNewswire · March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quantum Computing Inc. (NASDAQ: QUBT) between March 30, 2020 and January 15, 2025, both dates inclusive (the “Class Period”), of the important April 28, 2025 lead plaintiff deadline.
By The Rosen Law Firm PA · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today reported financial results for the full year ended December 31, 2024, and provided business highlights.
By Aardvark Therapeutics, Inc. · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today reported its fourth quarter and full-year 2024 operating and financial results and reviewed recent business highlights.
By Calidi Biotherapeutics, Inc · Via GlobeNewswire · March 31, 2025
REDWOOD CITY, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity medicines company, reported fourth quarter and full year 2024 financial results and corporate highlights.
By Biomea Fusion, Inc. · Via GlobeNewswire · March 31, 2025
CLAYMONT, Del., March 31, 2025 (GLOBE NEWSWIRE) -- Archimedes Tech SPAC Partners II Co. (Nasdaq: ATIIU) (the “Company”) today announced that, commencing April 3, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s ordinary shares and warrants included in the units.
By Archimedes Tech SPAC Partners II Co. · Via GlobeNewswire · March 31, 2025
By Allarity Therapeutics, Inc. · Via GlobeNewswire · March 31, 2025
Annualized Recurring Revenue ("ARR") of $836 million Grew 48% year-over-yearRevenue of $238 million Grew 29% year-over-yearShareFile Integration Underway
By Progress Software Corporation · Via GlobeNewswire · March 31, 2025
Management to Host Conference Call Today at 4:30 p.m. ET
By MDB Capital Holdings, LLC · Via GlobeNewswire · March 31, 2025
– Rademikibart demonstrated rapid onset of action with significant improvements in lung function observed at one week and maintained through 24 weeks –
By Connect Biopharma Holdings Limited · Via GlobeNewswire · March 31, 2025
Q4 Sequential Revenue Growth of 43% Driven by New Products and Technologies, and 131% Year over Year
By Expion360 · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, today announced that management will present at the 24th Annual Needham Virtual Healthcare Conference on Monday, April 7, 2025, at 11:00 a.m. EDT.
By Artiva Biotherapeutics, Inc. · Via GlobeNewswire · March 31, 2025
WALTHAM, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that an abstract detailing a post-hoc analysis of the OPTIMIZE Study, an open-label clinical trial of XPHOZAH ® (tenapanor), was accepted as a poster presentation at the National Kidney Foundation (NKF) Spring Clinical Meetings, to be held April 10-13, 2025, in Boston.
By Ardelyx, Inc. · Via GlobeNewswire · March 31, 2025
First Half Fiscal Year 2025 Revenue up 13.1% to $16.4 Million Period over Period
By Helport AI, Inc. · Via GlobeNewswire · March 31, 2025
LIMASSOL, Cyprus, March 31, 2025 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company (“GDEV” or the “Company”), released its financial and operational results for the fourth quarter and full year ended December 31, 2024.
By GDEV Inc. · Via GlobeNewswire · March 31, 2025
HOUSTON, March 31, 2025 (GLOBE NEWSWIRE) -- Kirby Corporation ("Kirby") (NYSE: KEX) will announce its 2025 first quarter results at 6:00 a.m. Central Daylight Time (“CDT”) on Thursday, May 1, 2025. This announcement will be followed by an earnings conference call webcast at 7:30 a.m. CDT.
By Kirby Corporation · Via GlobeNewswire · March 31, 2025
Niagara Falls, NY, March 31, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (OTC: POSC) (the “Company”), a leading molecular imaging medical device company specializing in Positron Emission Tomography (PET) and PET-CT imaging systems and clinical support services, is pleased to announce it has secured $8 million in capital to accelerate its expansion in the PET-CT market and further strengthen its position as a premier provider of advanced imaging technology and services for nuclear cardiology and oncology. The investment was exclusively equity based, offering 8 million shares of its common stock to two strategic investors.
By Positron Corp. · Via GlobeNewswire · March 31, 2025
BUENA PARK, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- Yoshiharu Global Co. (NASDAQ: YOSH) ("Yoshiharu" or the "Company"), a restaurant operator specializing in authentic Japanese ramen & rolls, today announced that it has received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has regained compliance with the minimum stockholders’ equity requirement under Nasdaq Listing Rule 5550(b)(1). The Company’s security will continue to be listed and traded on The Nasdaq Stock Market.
By Yoshiharu Global Co. · Via GlobeNewswire · March 31, 2025
ATLANTA, March 31, 2025 (GLOBE NEWSWIRE) -- Gray Media, Inc. (“Gray” or the “Company”) (NYSE: GTN) today announced that it has increased the aggregate commitments under its revolving accounts receivable securitization facility (the “AR Facility”) by $100 million, resulting in aggregate commitments under the AR Facility of up to $400 million, and extended the maturity of the facility from February 23, 2026 to March 31, 2028.
By Gray Media · Via GlobeNewswire · March 31, 2025
Wellness brand celebrates growth and leadership during Women’s History Month
By Franworth · Via GlobeNewswire · March 31, 2025
The new unit was developed in response to the increase of liver disease seen across the country.
By VCU Health · Via GlobeNewswire · March 31, 2025
TORONTO, March 31, 2025 (GLOBE NEWSWIRE) -- PDAC was encouraged to see a two-year extension of the Mineral Exploration Tax Credit (METC) announced on March 2, 2025, but legislation has not materialized. Ultimately, a long-term solution is essential to provide the certainty needed to reverse the decade-long decline in equity investment in grassroots exploration across Canada.
By Prospectors & Developers Association of Canada (PDAC) · Via GlobeNewswire · March 31, 2025
All amounts are in United States dollars, unless otherwise stated.
By Alamos Gold Inc. · Via GlobeNewswire · March 31, 2025
VICTORIA, Seychelles, March 31, 2025 (GLOBE NEWSWIRE) -- The globally renowned crypto exchange BYDFi today announced the global listing of the GUNZ token($GUN), the native asset of the GUNZ Layer1 blockchain developed by German AAA game studio Gunzilla Games. As one of the first crypto economies purpose-built for AAA gaming, GUNZ is rapidly emerging as a standout Web3 project thanks to its strong institutional backing and groundbreaking infrastructure tailored for next-generation gaming.
By BYDFi Blockchain Limited · Via GlobeNewswire · March 31, 2025
GQG US Equity ETF (GQUS) will launch in summer 2025
By GQG Partners · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of those who purchased or otherwise acquired Fluence Energy, Inc. (NASDAQ: FLNC) securities between November 29, 2023 and February 10, 2025. Fluence, through its subsidiaries, offers energy storage products and solutions, delivery services, recurring operational and maintenance services, and digital applications and solutions for energy storage and other power assets.
By Robbins LLP · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Actinium Pharmaceuticals, Inc. (NYSE: ATNM) securities between October 31, 2022 and August 2, 2024. Actinium is a late-stage biopharmaceutical company that develops targeted radiotherapies, such as Iomab-B, to treat people who have failed existing oncology therapies.
By Robbins LLP · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · March 31, 2025
CAMARILLO, Calif., March 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Newton Golf Company (Nasdaq: NWTG), a developer of performance-focused golf equipment, today announced it will host an earnings call to discuss its fourth quarter and full-year 2024 financial results on Monday, March 31, 2025 at 4:30PM ET.
By Newton Golf Company · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons or entities who purchased or otherwise acquired Mullen Automotive, Inc. (NASDAQ: MULN) securities between February 3, 2023 and March 13, 2024. Mullen purports to be an electronic vehicle (“EV”) manufacturer.
By Robbins LLP · Via GlobeNewswire · March 31, 2025
NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) --
By The Rosen Law Firm PA · Via GlobeNewswire · March 31, 2025
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · March 31, 2025